Consort Medical plc operates as a one-stop developer and manufacturer of drugs and premium drug delivery devices. It operates through two divisions, Bespak and Aesica. The company provides various life improving treatments to patients across worldwide through the design, development, and manufacture of medical devices for inhaled, injectable, nasal, and ocular drug delivery, as well as point of care diagnostics products. It also develops, formulates, and manufactures active pharmaceutical ingredients and finished dose drugs. Consort Medical plc was incorporated in 1946 and is based in Hemel Hempstead, the United Kingdom.
Industry, Sector and Symbol
Stock Exchange LON
Industry Medical Appliances & Equipment
Sub-IndustryN/A
SectorMedical
Current SymbolLON:CSRT
Previous Symbol
CUSIPN/A
Phone+44-1442-867920
Debt
Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A
Price-To-Earnings
Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A
Sales & Book Value
Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / Cash FlowN/A
Book ValueN/A
Price / BookN/A
Profitability
EPS (Most Recent Fiscal Year)N/A
Net IncomeN/A
Net MarginsN/A
Return on EquityN/A
Return on AssetsN/A
Miscellaneous
Employees2,000
Outstanding SharesN/A
Market Cap£0.00
OptionableNot Optionable
Consort Medical (LON:CSRT) Frequently Asked Questions
What is Consort Medical's stock symbol?
Consort Medical trades on the London Stock Exchange (LON) under the ticker symbol "CSRT."
How often does Consort Medical pay dividends? What is the dividend yield for Consort Medical?
Consort Medical declared a dividend on Tuesday, December 4th. Stockholders of record on Thursday, January 17th will be paid a dividend of GBX 7.60 per share on Friday, February 15th. This represents a dividend yield of 0.99%. The ex-dividend date of this dividend is Thursday, January 17th. The official announcement can be viewed at this link. View Consort Medical's Dividend History.
What price target have analysts set for CSRT?
3 equities research analysts have issued 12-month price objectives for Consort Medical's stock. Their predictions range from GBX 1,215 to GBX 1,333. On average, they anticipate Consort Medical's stock price to reach GBX 1,289.33 in the next twelve months. This suggests a possible upside of 75.2% from the stock's current price. View Analyst Price Targets for Consort Medical.
What is the consensus analysts' recommendation for Consort Medical?
3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Consort Medical in the last year. There are currently 2 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Consort Medical.
Has Consort Medical been receiving favorable news coverage?
Press coverage about CSRT stock has trended positive on Friday, according to InfoTrie Sentiment Analysis. The research group identifies negative and positive press coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. Consort Medical earned a news impact score of 3.0 on InfoTrie's scale. They also gave news stories about the company a news buzz of 2.0 out of 10, meaning that recent press coverage is very unlikely to have an impact on the stock's share price in the immediate future.
Who are some of Consort Medical's key competitors?
Some companies that are related to Consort Medical include Bioquell (BQE), Corindus Vascular Robotics (CVRS), Deltex Medical Group (DEMG), Ekf Diagnostics (EKF), Immunodiagnostic Systems (IDH), InspireMD (NSPR), LiDCO Group (LID), Lucid (LCDX), Medaphor Group (MED), Smith & Nephew (SN), Theralase Technologies (TLT), Verisante Technology (VRS) and Zecotek Photonics (ZMS).
Who are Consort Medical's key executives?
Consort Medical's management team includes the folowing people:
- Mr. Jonathan M. Glenn, CEO & Director (Age 49)
- Mr. Paul Hayes, CFO & Exec. Director (Age 51)
- Mr. Andrew Jackson, Group Gen. Counsel & Company Sec.
- Ms. Lisa King, Director of HR
- Colin Leeder, Group Financial Controller
How do I buy shares of Consort Medical?
Shares of CSRT and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
What is Consort Medical's stock price today?
One share of CSRT stock can currently be purchased for approximately GBX 736.
What is Consort Medical's official website?
How can I contact Consort Medical?
Consort Medical's mailing address is Ste D, Breakspear Park, Breakspear Way, HEMEL HEMPSTEAD, HP2 4TZ, United Kingdom. The company can be reached via phone at +44-1442-867920.
MarketBeat Community Rating for Consort Medical (LON CSRT)
MarketBeat's community ratings are surveys of what our community members think about Consort Medical and other stocks. Vote "Outperform" if you believe CSRT will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CSRT will underperform the S&P 500 over the long term. You may vote once every thirty days.
